NDC 17228-0777-00: Ticagrelor 90 mg Tablet, Film Coated, Drum of 25,000
This is a package of 25,000 tablets of Ticagrelor 90 mg Tablet, Film Coated from AstraZeneca AB, first listed with the FDA Jul 2011 and currently FDA-listed. It is this product's only package size.
NDC database record
One package, one record: these facts belong to NDC 17228-0777-0 alone.
- Record
- FDA NDC Directory package listing · Drug for further processing
- Code segments
- 17228 labeler · 0777 product · 0 package
- Package marketed since
- Jul 20, 2011
- Listing certified through
- Dec 31, 2027
- Barcode (UPC-A, from the NDC)
- 3 1722807770 8
- FDA record last changed
- Nov 12, 2026
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
- RxNorm (NLM RxNav) · catalog refreshed Nov 19, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Nov 19, 2026
Clinical
- Don't double up. Just take your next dose at its regular time. If you often forget doses, tell your pharmacist or doctor, because this medicine works best when taken steadily.
- What happens if I miss a dose of Ticagrelor?
- Please don't stop on your own. Stopping raises your risk of heart attack, stroke and death. If you need to pause it, for example for surgery or bleeding, your doctor will tell you...
- Shortness of breath is one of the most common side effects. It is usually mild to moderate and often improves as you keep taking it. Tell your doctor if it is new, lasts a while or...
Patient education
Drug interactions
Supplement & herbal interactions
Some supplements/herbs that may interact with Ticagrelor — tap one for details:
Where does this data come from?
- MedlinePlus (NLM) · refreshed Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per each | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
Where does this data come from?
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Nov 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Nov 19, 2026
- CMS Part D plan pricing files · refreshed Oct 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 17228-0777-00 You're viewing this Main listing | 25000 TABLET, FILM COATED in 1 DRUM | — | — | Active |
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Ticagrelor 90 mg 67877-0491-05 | Ascend | 500 tablets | $0.243 | AB | Availability likely | — |
| Ticagrelor 90 mg 00378-2215-91 | Mylan | 60 tablets | $0.243 | AB | Availability likely | — |
| Ticagrelor 90 mg 33342-0432-09 | Macleods | 60 tablets | $0.243 | AB | Availability likely | — |
| Ticagrelor 90 mg 60505-4452-06 | Apotex | 60 tablets | $0.243 | AB | Availability likely | — |
| Ticagrelor 90 mg 72516-0018-06 | Oryza | 60 tablets | $0.243 | AB | Availability likely | — |
| Ticagrelor 90 mg 42658-0115-03 | Hisun | 60 tablets | $0.243 | AB | Availability likely | — |
| Ticagrelor 90 mg 50268-0826-01 | AvPAK | 100 tablets | $0.243 | AB | Availability likely | — |
| Ticagrelor 90 mg 69452-0509-17 | BIONPHARMA | 60 tablets | $0.243 | AB | Availability likely | — |
| Ticagrelor 90 mg 11788-0158-01 | AiPing | 100 tablets | $0.243 | AB | Availability likely | — |
| Ticagrelor 90 mg 60687-0928-57 | American | 60 tablets | $0.243 | AB | Availability likely | — |
| Ticagrelor 90 mg 00480-2695-06 | Teva | 60 tablets | $0.243 | AB | Availability likely | — |
| Brilinta 90 mg 55154-9618-00 | Cardinal | 10 tablets | — | AB | FDA listed | — |
| ticagrelor 90 mg 77771-0522-60 | Radha | 60 tablets | — | AB | FDA listed | — |
| Ticagrelor 90 mg 62332-0241-30 | Alembic | 30 tablets | — | AB | FDA listed | — |
| Ticagrelor 90 mg 69097-0991-03 | Cipla | 60 tablets | — | AB | FDA listed | — |
| Ticagrelor 90 mg 51407-0861-60 | Golden | 60 tablets | — | AB | FDA listed | — |
| Ticagrelor 90 mg 71610-0914-41 | Aphena | 5400 tablets | — | AB | FDA listed | — |
| Ticagrelor 90 mgthis 17228-0777-00 | AstraZeneca | 25000 tablets | — | — | FDA listed | — |
| Ticagrelor 90 mg 43598-0480-18 | Dr. | 180 tablets | — | AB | FDA listed | — |
| Brilinta 90 mg 00186-0777-08 | AstraZeneca | 8 tablets | — | AB | Discontinued | — |
| Ticagrelor 90 mg 71610-0958-41 | Aphena | 5400 tablets | — | AB | FDA listed | — |
| Ticagrelor 90 mg 43547-0657-06 | Solco | 60 tablets | — | AB | FDA listed | — |
| Brilinta 90 mg 71610-0815-41 | Aphena | 5400 tablets | — | AB | FDA listed | — |
| Ticagrelor 90 mg 76282-0550-01 | Exelan | 100 tablets | — | AB | FDA listed | — |
| Ticagrelor 90 mg 46708-0241-30 | Alembic | 30 tablets | — | AB | FDA listed | — |
| Ticagrelor 90 mg 55488-0543-01 | Changzhou | 60 tablets | — | AB | FDA listed | — |
| ticagrelor 90 mg 50228-0522-10 | ScieGen | 1000 tablets | — | AB | FDA listed | — |
| Ticagrelor 90 mg 72205-0368-11 | Novadoz | 100 tablets | — | AB | FDA listed | — |
| Ticagrelor 90 mg 70756-0048-60 | Lifestar | 60 tablets | — | AB | FDA listed | — |
| Ticagrelor 90 mg 73190-0008-60 | AvKARE | 60 tablets | — | AB | FDA listed | — |
| Ticagrelor 90 mg 67296-2268-02 | Redpharm | 7 tablets | — | AB | FDA listed | — |
| Ticagrelor 90 mg 72603-0941-01 | NorthStar | 60 tablets | — | AB | FDA listed | — |
| Ticagrelor 90 mg 53401-0028-42 | Aphena | 1800 tablets | — | AB | FDA listed | — |
| Ticagrelor 90 mg 42385-0994-01 | Laurus | 100 tablets | — | AB | FDA listed | — |
| Ticagrelor 90 mg 42571-0263-05 | Micro | 500 tablets | — | AB | FDA listed | — |
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA Orange Book · refreshed Nov 6, 2026
- CMS NADAC weekly file
Availability & generic status
FDA-approved generic versions are listed, and recent pricing/market data suggests they may be available — see Therapeutic equivalents.
Where does this data come from?
- FDA Orange Book · refreshed Nov 6, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
🧪 Avoiding an ingredient? See Ticagrelor inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.
Where does this data come from?
IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.- FDA label on DailyMed · label index refreshed Nov 21, 2026
- FDA openFDA NDC Directory · synced Nov 19, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
Why might an inactive ingredient be missing?
Can inactive ingredients matter?
Manufacturer & labeler
More NDCs from AstraZeneca AB labeler code 17228
- Selumetinib 7.5 mg Capsule NDC 17228-0640-0
- olaparib 100 mg Tablet, Film Coated NDC 17228-0668-0
- olaparib 150 mg Tablet, Film Coated NDC 17228-0679-0
- Omeprazole magnesium 20.6 mg Tablet, Delayed Release NDC 17228-0740-9
- omeprazole magnesium 20 mg Tablet, Delayed Release NDC 17228-0750-9
- Ticagrelor 60 mg Tablet, Film Coated NDC 17228-0776-0
- Metoprolol succinate 25 mg Tablet, Extended Release NDC 17228-1088-9
- Osimertinib 40 mg Tablet, Film Coated NDC 17228-1349-0
- Osimertinib 80 mg Tablet, Film Coated NDC 17228-1350-0
- Budesonide Micronized 3.4 kg/3.4kg Powder NDC 17228-1991-0
- Benralizumab 30 mg/mL Injection, Solution NDC 17228-2730-0
- Durvalumab 120 mg/2.4mL Injection, Solution NDC 17228-4500-1
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- Drugs@FDA
Full FDA label FDA SPL
📄 FDA label ▾
No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.
Medicare Part D spend CMS · PART D · 2026 (Q1)
Reported adverse events (FAERS)
Top reported reactions
Age at onset
Reporter sex
Serious outcomes
Where does this data come from?
About this NDC listing & data coverage
What "drug for further processing" means
FDA lists this package under the "drug for further processing" marketing category: AstraZeneca AB supplies it to other companies for further processing or repackaging (blister cards that are later repackaged or co-packaged are a common example). The units themselves are a finished dosage form — which is why pricing or Medicaid data can still appear — but this exact package code may not be the presentation a retail pharmacy dispenses.
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | — Not published for this NDC No photo available yet for this listing. |
| Inactive ingredients (structured) | — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available. |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |